4D Molecular Therapeutics, Inc.
Revenue Breakdown
| Fiscal Year | Product Revenue | License Revenue |
|---|---|---|
| FY2017 | $14.6M | $3.6M |
| FY2018 | $22.1M | $3.4M |
| FY2019 | $25.3M | $1.2M |
| FY2020 | $24.4M | $0 |
| FY2021 | $29.8M | $0 |
| FY2022 | $35.4M | $0 |
| FY2023 | $38.2M | $0 |
Revenue Breakdown
| Fiscal Year | Product Revenue | License Revenue |
|---|---|---|
| FY2017 | $14.6M | $3.6M |
| FY2018 | $22.1M | $3.4M |
| FY2019 | $25.3M | $1.2M |
| FY2020 | $24.4M | $0 |
| FY2021 | $29.8M | $0 |
| FY2022 | $35.4M | $0 |
| FY2023 | $38.2M | $0 |